NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 31 filers reported holding NOVELION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,015,000 | -27.7% | 1,400,000 | -22.2% | 1.83% | -30.4% |
Q2 2019 | $1,404,000 | -36.6% | 1,800,000 | 0.0% | 2.63% | -69.1% |
Q1 2019 | $2,214,000 | +43.0% | 1,800,000 | 0.0% | 8.53% | +41.8% |
Q4 2018 | $1,548,000 | -48.3% | 1,800,000 | +78.0% | 6.02% | -16.9% |
Q3 2018 | $2,994,000 | -38.1% | 1,011,487 | -23.0% | 7.24% | -47.1% |
Q2 2018 | $4,833,000 | +38.1% | 1,313,387 | +31.3% | 13.70% | -5.8% |
Q1 2018 | $3,500,000 | +12.2% | 1,000,000 | 0.0% | 14.55% | +53.3% |
Q4 2017 | $3,120,000 | -49.7% | 1,000,000 | +13.5% | 9.49% | -23.5% |
Q3 2017 | $6,197,000 | -19.2% | 881,440 | +6.0% | 12.40% | -10.1% |
Q2 2017 | $7,674,000 | -14.1% | 831,440 | 0.0% | 13.79% | -9.7% |
Q1 2017 | $8,930,000 | +27.6% | 831,440 | 0.0% | 15.27% | +103.7% |
Q4 2016 | $7,001,000 | – | 831,440 | – | 7.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
Prosight Management, LP | 194,663 | $716,000 | 0.52% |
ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |